cushingoid appearance

cushingoid appearance

An appearance of Pts with Cushing syndrome, which consists of 'moon' faces, truncal obesity, abdominal striae, atrophied skin, and hyperpigmentation of skin folds
References in periodicals archive ?
Physically, she exhibited cushingoid appearance and complained of excessive weight gain and hair growth on the body.
Complications encountered in Group B were namely, Cushingoid appearance (n=12), GI upset (n=5), recurrence (n=6) and infection (n=3) (Fig.
Additionally, her chronic AIHA came under control after 1 week of MDMP treatment, hemoglobinuria resolved and the bilirubin level decreased after 3 d of MDMP; the only side effect was a mild cushingoid appearance that regressed after 2 months of the treatment, despite continuation of a relatively low dose of MP (48 mg/d).
Cushingoid appearance manifests as moon facies, truncal obesity, and "buffalo hump," and is very troubling to patients, but is uncommon at doses below the physiologic glucocorticoid replacement range.
She experienced extreme anxiety, paranoia, agitation, insomnia and behavioural changes, and some associated systemic effects including developing a cushingoid appearance, alopecia, systemic and ocular hypertension, nausea and hypercholesterolemia.
Dermatoiogical changes can occur with steroid therapy, including a redistribution of subcutaneous fat causing the cushingoid appearance of central obesity, hump back, and moon face.
Physical examination revealed a slightly cushingoid appearance and the patient was incontinent of urine.
Complications included steroid-related side effects--such as hyperphagia, a cushingoid appearance, and a herpetic esophageal ulcer--in 11 of the patients treated with prednisone.
In a patient of cushingoid appearance, a 24-hour urine cortisol test or low-dose dexamethasone suppression test is useful.
Most complications are infectious or are secondary to steroid including: increase appetite, Cushingoid appearance, and hyperactivity.
13,14) Long-term corticosteroid use can lead to hypertension, hyperglycemia, diabetes, osteoporosis, cushingoid appearance, proximal myopathy, peptic ulceration, increased susceptibility to infections, and psychiatric disorders.
Cushingoid appearance and delayed healing of the cervical ulcerated lesion in the present case were attributed to prolonged use of systemic MPZ.